Literature DB >> 7924741

Enhancement by tocoretinate of epidermal growth factor-induced DNA synthesis in human intestinal epithelial cells.

N Kawamura1, K Miki, K Kurokawa, I Kojima.   

Abstract

Tocoretinate (TR) is a hybrid compound composed of alpha-tocopherol esterified with retinoic acid. The present study was conducted to clarify whether or not TR affects DNA synthesis in a human intestinal cell line, FHs 74 Int. In these cells, addition of 10% serum resulted in an approximately 10-fold increase in DNA synthesis as assessed by [3H]thymidine incorporation. Epidermal growth factor (EGF) augmented DNA synthesis three- to fourfold. When EGF was added together with insulin-like growth factor-I (IGF-I), which had only a small effect by itself, a combination of these growth factors reproduced the effect of serum. In quiescent FHs 74 Int cells, TR had no effect on DNA synthesis by itself. However, when quiescent cells were pretreated with TR for 24 hr, DNA synthesis induced by EGF was markedly enhanced. Thus, in TR-pretreated cells, EGF stimulated DNA synthesis to the same extent as 10% serum. The effect of TR was dose-dependent and the maximal effect was obtained by 10(-7) M TR. Pretreatment with TR enhanced the effect of EGF on DNA synthesis but did not change the dose-response relationship for EGF-mediated DNA synthesis. All-trans-retinoic acid had similar stimulatory effect on EGF-induced DNA synthesis. When the medium was changed during the treatment with TR, the effect of TR on DNA synthesis was reduced. In addition, pretreatment with TR resulted in release of immunoreactive IGF-I into medium. Finally, the effect of TR was attenuated by an addition of antibody against IGF-I.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7924741     DOI: 10.1007/bf02090370

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  9 in total

1.  Insulin-like growth factor II stimulates calcium influx in competent BALB/c 3T3 cells primed with epidermal growth factor. Characteristics of calcium influx and involvement of GTP-binding protein.

Authors:  I Nishimoto; Y Hata; E Ogata; I Kojima
Journal:  J Biol Chem       Date:  1987-09-05       Impact factor: 5.157

2.  Consumption of EGF by A431 cells: evidence for receptor recycling.

Authors:  H Masui; L Castro; J Mendelsohn
Journal:  J Cell Biol       Date:  1993-01       Impact factor: 10.539

3.  Role of retinoids in differentiation and carcinogenesis.

Authors:  M B Sporn; A B Roberts
Journal:  Cancer Res       Date:  1983-07       Impact factor: 12.701

4.  Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C.

Authors:  D Boscoboinik; A Szewczyk; C Hensey; A Azzi
Journal:  J Biol Chem       Date:  1991-04-05       Impact factor: 5.157

5.  Insulin-like growth factor-I and its N-terminal modified analogues induce marked gut growth in dexamethasone-treated rats.

Authors:  L C Read; F M Tomas; G S Howarth; A A Martin; K J Edson; C M Gillespie; P C Owens; F J Ballard
Journal:  J Endocrinol       Date:  1992-06       Impact factor: 4.286

6.  Modulation of growth of vascular smooth muscle cells by activin A.

Authors:  I Kojima; H Mogami; N Kawamura; H Yasuda; H Shibata
Journal:  Exp Cell Res       Date:  1993-05       Impact factor: 3.905

7.  Nuclear ultrastructure of epithelial cell lines derived from human carcinomas and nonmalignant tissues.

Authors:  H S Smith; E L Springer; A J Hackett
Journal:  Cancer Res       Date:  1979-02       Impact factor: 12.701

8.  Radioimmunoassay for insulin-like growth factor I (IGF-I) using biosynthetic IGF-I.

Authors:  M Miyakawa; N Hizuka; K Takano; I Tanaka; R Horikawa; N Honda; K Shizume
Journal:  Endocrinol Jpn       Date:  1986-12

9.  Somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II mRNAs in rat fetal and adult tissues.

Authors:  P K Lund; B M Moats-Staats; M A Hynes; J G Simmons; M Jansen; A J D'Ercole; J J Van Wyk
Journal:  J Biol Chem       Date:  1986-11-05       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.